A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine

Retina

Volumn 28, Issue 10, 2008, Pages 1478-1486

  Chang, Wellington H ^a,b   Katz, Bradley J ^a   Warner, Judith E A ^a   Vitale, Albert T ^a   Creel, Donnell ^a   Digre, Kathleen B ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLOR VISION; ELECTRORETINOGRAPHY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERRATER RELIABILITY; LUPUS VULGARIS; MEDICAL RECORD REVIEW; READING; RETINA; RETINA DISEASE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; TREATMENT DURATION; VISION TEST; VISUAL ACUITY; VISUAL FIELD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; REPRODUCIBILITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIMALARIALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL DISEASES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME; VISUAL FIELDS;

EID: 58949086354     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318181445b     Document Type: Article

References (9)

1. Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 2003;110:1321-1326.
2. Levy GD, Munz SJ, Paschal J, et al. Incidence of hydroxychlo- roquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997;40:1482-1486.
3. Marmor MF, Carr RE, Easterbrook M, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2002;109:1377-1382.
4. So SC, Hedges TR, Schuman JS, Quireza ML. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging 2003;34:251-258.
5. Penrose PJ, Tzekov RT, Sutter EE, et al. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 2003;23:503-512.
6. Maturi RK, Yu M, Weleber RG. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 2004;122:973-981.
7. Lai TY, Chan WM, Li H, et al. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 2005;140:794-807.
8. Lyons JS, Severns ML. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol 2007;143:801-809.
9. Marmor MF. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG. Am J Ophthalmol 2005;140:894-895.